Advertisement

Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 650x80px
Document › Details

MolMed S.p.A.. (3/9/20). "Press Release: The Board of Directors Approved the 2019 Full Year Financial Results". Milan.

Organisations Organisation MolMed S.p.A. (MLMD.MI)
  Group Asahi Glass (AGC) (Group)
  Organisation 2 Autolus Therapeutics Ltd.
  Today Autolus Therapeutics plc (Nasdaq: AUTL)
  Group Autolus Therapeutics plc (Nasdaq: AUTL)
Products Product contract manufacturing (biologicals)
  Product 2 Zalmoxis®
Persons Person Palmisano, Riccardo (MolMed 201606 CEO)
  Person 2 Incerti, Carlo (Forbion 201901– Operating Partner before Sanofi Genzyme + Genzyme + Biofil Srl)
     


   
Record changed: 2020-03-25

Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px

More documents for Asahi Glass (AGC) (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px




» top